Mananghac, Sheila .

HRN: 06-46-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFUROXIME 500MG (TAB)
03/25/2024
03/31/2024
PO
500mg Tab
BID
Post NSVD With 2nd Deg Laceration And Repair; PROM X 6 Hours
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: